We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ESRX
176
DELISTED
Express Scripts Holding Company
ESRX
| $2.68M | 0.05% |
30,871
-23
| -0.1% | -$1.93K |
2013 Q2
7 quarters
|
|
177
Oracle
ORCL
$408B
| $2.67M | 0.05% |
61,945
-5,068
| -8% | -$220K |
2013 Q2
7 quarters
|
|
178
Verizon
VZ
$184B
| $2.67M | 0.05% |
54,827
-2,015
| -4% | -$97.3K |
2013 Q2
7 quarters
|
|
179
DELISTED
EMC CORPORATION
EMC
| $2.57M | 0.05% |
100,690
-12,559
| -11% | -$346K |
2013 Q2
7 quarters
|
|
180
General Mills
GIS
$17.6B
| $2.55M | 0.05% |
45,114
-4,712
| -9% | -$251K |
2013 Q2
7 quarters
|
|
181
Caterpillar
CAT
$338B
| $2.53M | 0.05% |
31,660
-741
| -2% | -$61.6K |
2013 Q2
7 quarters
|
|
182
Marsh
MRSH
$89B
| $2.52M | 0.05% |
44,840
| – | – |
2013 Q4
5 quarters
|
|
183
Altria Group
MO
$123B
| $2.49M | 0.05% |
49,822
+241
| +0.5% | +$12.8K |
2013 Q2
7 quarters
|
|
184
Grand Canyon Education
LOPE
$4.21B
| $2.49M | 0.05% |
57,527
-17,689
| -24% | -$793K |
2013 Q2
7 quarters
|
|
185
Novartis
NVS
$286B
| $2.49M | 0.05% |
28,152
-4,143
| -13% | -$367K |
2013 Q2
7 quarters
|
|
186
O'Reilly Automotive
ORLY
$71.6B
| $2.45M | 0.04% |
169,950
| – | – |
2013 Q2
7 quarters
|
|
187
ConocoPhillips
COP
$170B
| $2.41M | 0.04% |
38,759
-2,884
| -7% | -$186K |
2013 Q2
7 quarters
|
|
188
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $2.33M | 0.04% |
8,408
+200
| +2% | +$53.9K |
2013 Q2
7 quarters
|
|
189
CHS Inc Class B Preferred Stock
CHSCO
$549M
| $2.29M | 0.04% |
80,105
-500
| -0.6% | -$14.2K |
2013 Q3
6 quarters
|
|
190
DELISTED
Annaly Capital Management, Inc. 7.50% Series D Cumulative Redeemable Preferred Stock
NLY.PRD
| $2.26M | 0.04% |
89,795
+2,800
| +3% | +$70.6K |
2013 Q2
7 quarters
|
|
191
Cisco
CSCO
$433B
| $2.24M | 0.04% |
81,308
-2,585
| -3% | -$72.8K |
2013 Q2
7 quarters
|
|
192
Criteo S.A.
CRTO
$772M
| $2.23M | 0.04% |
+56,539
| New | +$2.35M |
2015 Q1
0 quarters
|
|
193
iShares Core S&P 500 ETF
IVV
$889B
| $2.21M | 0.04% |
10,655
+508
| +5% | +$106K |
2013 Q2
7 quarters
|
|
194
United Rentals
URI
$65.2B
| $2.19M | 0.04% |
24,079
-147,205
| -86% | -$13.2M |
2014 Q1
4 quarters
|
|
195
Canadian National Railway
CNI
$72.9B
| $2.19M | 0.04% |
32,761
-60,752
| -65% | -$4.13M |
2013 Q2
7 quarters
|
|
196
Monster Beverage
MNST
$88.8B
| $2.16M | 0.04% |
187,080
+34,380
| +23% | +$360K |
2014 Q4
1 quarter
|
|
197
DELISTED
Air Lease Corp
AL
| $2.14M | 0.04% |
56,730
-150
| -0.3% | -$5.51K |
2014 Q1
4 quarters
|
|
|
NJ
198
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $2.11M | 0.04% |
+126,280
| New | +$2.12M |
2015 Q1
0 quarters
|
|
199
Embraer S.A. ADS
EMBJ
$12.8B
| $2.11M | 0.04% |
68,496
-37,371
| -35% | -$1.27M |
2014 Q1
4 quarters
|
|
200
The Mosaic Company
MOS
$6.02B
| $2.05M | 0.04% |
44,578
-388
| -0.9% | -$18.9K |
2013 Q2
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.